Cited by 291Epilepsy research and treatmentAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections.

Open access
Tai, Xin You, Koepp, Matthias, Duncan, John S., Fox, Nick, Thompson, Pamela, Baxendale, Sallie, Liu, Joan Y. W., Reeves, Cheryl +2 more·2016·Brain

Abstract

SEE BERNASCONI DOI101093/AWW202 FOR A SCIENTIFIC COMMENTARY ON THIS ARTICLE: Temporal lobe epilepsy, the most prevalent form of chronic focal epilepsy, is associated with a high prevalence of cognitive impairment but the responsible underlying pathological mechanisms are unknown. Tau, the microtubule-associated protein, is a hallmark of several neurodegenerative diseases including Alzheimer's disease and chronic traumatic encephalopathy. We hypothesized that hyperphosphorylated tau pathology is associated with cognitive decline in temporal lobe epilepsy and explored this through clinico-pathological study. We first performed pathological examination on tissue from 33 patients who had undergone temporal lobe resection between ages 50 and 65 years to treat drug-refractory temporal lobe epilepsy. We identified hyperphosphorylated tau protein using AT8 immunohistochemistry and compared this distribution to Braak patterns of Alzheimer's disease and patterns of chronic traumatic encephalopathy. We quantified tau pathology using a modified tau score created specifically for analysis of temporal lobectomy tissue and the Braak staging, which was limited without extra-temporal brain areas available. Next, we correlated tau pathology with pre- and postoperative cognitive test scores and clinical risk factors including age at time of surgery, duration of epilepsy, history of secondary generalized seizures, history of head injury, handedness and side of surgery. Thirty-one of 33 cases (94%) showed hyperphosphorylated tau pathology in the form of neuropil threads and neurofibrillary tangles and pre-tangles. Braak stage analysis showed 12% of our epilepsy cohort had a Braak staging III-IV compared to an age-matched non-epilepsy control group from the literature (8%). We identified a mixture of tau pathology patterns characteristic of Alzheimer's disease and chronic traumatic encephalopathy. We also found unusual patterns of subpial tau deposition, sparing of the hippocampus and co-localization with mossy fibre sprouting, a feature of temporal lobe epilepsy. We demonstrated that the more extensive the tau pathology, the greater the decline in verbal learning (Spearman correlation, r = -0.63), recall (r = -0.44) and graded naming test scores (r = -0.50) over 1-year post-temporal lobe resection (P < 0.05). This relationship with tau burden was also present when examining decline in verbal learning from 3 months to 1 year post-resection (r = -0.54). We found an association between modified tau score and history of secondary generalized seizures (likelihood-ratio χ(2), P < 0.05) however there was no clear relationship between tau pathology and other clinical risk factors assessed. Our findings suggest an epilepsy-related tauopathy in temporal lobe epilepsy, which contributes to accelerated cognitive decline and has diagnostic and treatment implications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/aww187

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased total and p-tau levels measured in surgically resected tissue from temporal lobe epilepsy patients are inversely correlated with cognitive scores.

    “and increased total and p-tau levels measured in surgically resected tissue from TLE patients are inversely correlated with cognitive scores (Kandratavicius et al., 2013; Tai et al., 2016; Gourmaud et al., 2020).”

    From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Tai et al., 2016

    The Methods (Analysis of tau and amyloid pathology; page unavailable) describe a score of hyperphosphorylated-tau staining in resected temporal lobe tissue, not measurements of both total tau and p-tau levels. The Results (Modified tau score in relation to age and cognitive testing; page unavailable) report negative correlations with changes in verbal learning, recall, and naming scores over the year after surgery, but no significant correlation with preoperative scores. The claim is supported for p-tau burden and subsequent cognitive decline, not for total tau levels or cognitive scores generally. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Observations of subpial bands formed by cortical p-tau depositions have been made across separate studies, providing evidence for a novel pattern of tau pathology in temporal lobe epilepsy that may result from seizure-induced reorganization of temporal lobe networks.

    “Interestingly, observations of subpial bands formed by cortical p-tau depositions have been made across separate studies (Puvenna et al., 2016; Tai et al., 2016; Smith et al., 2019), providing evidence for a novel pattern of tau pathology in TLE that may result from seizure-induced reorganization of temporal lobe networks (Tai et al., 2018).”

    From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Tai et al., 2016

  • Analysis of resected temporal lobe tissue by Tai et al. (2016) found pathological tau phosphorylation in the form of neuropil threads, neurofibrillary tangles, and pre-tangles in 31 of 33 temporal lobe epilepsy patients between 50 and 65 years of age.

    “For instance, analysis of resected temporal lobe tissue by Tai et al. (2016) found pathological tau phosphorylation in the form of neuropil threads, NFTs, and pre-tangles in 31 of 33 TLE patients between 50 and 65 years of age.”

    From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Tai et al., 2016

  • In humans with chronic epilepsy, elevated p-tau is present in post-mortem as well as surgically resected tissue.

    “And in humans with chronic epilepsy, elevated p-tau is present in post-mortem (Thom et al., 2011) as well as surgically resected tissue (Puvenna et al., 2016; Tai et al., 2016; Liu C. et al., 2017; Prada Jardim et al., 2018; Smith et al., 2019; Gourmaud et al., 2020).”

    From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Tai et al., 2016

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. Amador-Ortiz C, Lin W-L, Ahmed Z, Personett D, Davies P, Duara R, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease [Internet]. Ann Neurol 2007; 61: 435-45.
  2. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incidence and predictors of seizures in pa- tients with Alzheimer's disease [Internet]. Epilepsia 2006; 47: 867- 72.
  3. Bernhardt BC, Worsley KJ, Kim H, Evans AC, Bernasconi A, Bernasconi N. Longitudinal and cross-sectional analysis of atrophy Tau pathology in TLE BRAIN 2016: 139; 2441-2455 | 2453 in pharmacoresistant temporal lobe epilepsy [Internet]. Neurology 2009; 72: 1747-54.
  4. Black LC, Schefft BK, Howe SR, Szaflarski JP, Yeh H, Privitera MD. The effect of seizures on working memory and executive functioning performance [Internet]. Epilepsy Behav 2010; 17: 412-9.
  5. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years [Internet]. J Neuropathol Exp Neurol 2011; 70: 960-9.
  6. Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease [Internet]. Brain 2015; 138: 2814-33.
  7. Braak H, Zetterberg H, Del Tredici K, Blennow K. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-b changes occur before increases of tau in cerebrospinal fluid [Internet]. Acta Neuropathol 2013; 126: 631-41.
  8. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM. Abnormal tau phosphorylation at Ser396 in Alzheimer's dis- ease recapitulates development and contributes to reduced microtu- bule binding [Internet]. Neuron 1993; 10: 1089-99.
  9. Cormack F, Gadian DG, Vargha-Khadem F, Cross JH, Connelly A, Baldeweg T. Extra-hippocampal grey matter density abnormalities in paediatric mesial temporal sclerosis [Internet]. Neuroimage 2005; 27: 635-43.
  10. Dijkstra KK, Ferrier CH. Patterns and predictors of atypical language representation in epilepsy [Internet]. J Neurol Neurosurg Psychiatry 2013; 84: 379-85.
  11. Duyckaerts C, Braak H, Brion J-P, Bue ´e L, Del Tredici K, Goedert M, et al. PART is part of Alzheimer disease [Internet]. Acta Neuropathol 2015; 129: 749-56.
  12. Elger CE, Helmstaedter C, Kurthen M. Chronic epilepsy and cogni- tion. [Internet]. Lancet Neurol 2004; 3: 663-72.
  13. Gaitatzis A, Carroll K, Majeed A, W Sander J. The epidemiology of the comorbidity of epilepsy in the general population [Internet]. Epilepsia 2004; 45: 1613-22.
  14. Gavett BE, Stern RA, McKee AC. Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma [Internet]. Clin Sports Med 2011; 30: 179-88, xi.
  15. Goedert M, Spillantini MG. A century of Alzheimer's disease [Internet]. Science 2006; 314: 777-81.
  16. Griffith HR, Martin RC, Bambara JK, Faught E, Vogtle LK, Marson DC. Cognitive functioning over 3 years in community dwelling older adults with chronic partial epilepsy [Internet]. Epilepsy Res 2007; 74: 91-6.
  17. Griffith HR, Martin RC, Bambara JK, Marson DC, Faught E. Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment [Internet]. Epilepsy Behav 2006; 8: 161-8.
  18. Haneef Z, Lenartowicz A, Yeh HJ, Levin HS, Engel J, Stern JM. Functional connectivity of hippocampal networks in temporal lobe epilepsy [Internet]. Epilepsia 2014; 55: 137-45.
  19. Helmstaedter C, Elger CE. Chronic temporal lobe epilepsy: a neuro- developmental or progressively dementing disease? [Internet]. Brain 2009; 132: 2822-30.
  20. Hermann BP, Seidenberg M, Dow C, Jones J, Rutecki P, Bhattacharya A, et al. Cognitive prognosis in chronic temporal lobe epilepsy [Internet]. Ann Neurol 2006; 60: 80-7.
  21. Høgh P, Smith SJ, Scahill RI, Chan D, Harvey RJ, Fox NC, et al. Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment [Internet]. Neurology 2002; 58: 298-301.
  22. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models [Internet]. Cell 2010; 142: 387-97.
  23. Kandratavicius L, Monteiro MR, Hallak JE, Carlotti CG, Assirati JA, Leite JP. Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their rela- tion with granular cell layer dispersion [Internet]. Biomed Res Int 2013; 2013: 960126.
  24. Lee EB, Lee VM-Y, Trojanowski JQ, Neumann M. TDP-43 immunor- eactivity in anoxic, ischemic and neoplastic lesions of the central nervous system [Internet]. Acta Neuropathol 2008; 115: 305-11.
  25. Lewis J, Dickson DW. Propagation of tau pathology: hypotheses, dis- coveries, and yet unresolved questions from experimental and human brain studies [Internet]. Acta Neuropathol 2016; 131: 27-48.
  26. Lin JJ, Salamon N, Lee AD, Dutton RA, Geaga JA, Hayashi KM, et al. Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis [Internet]. Cereb Cortex 2007; 17: 2007-18.
  27. Liu YWJ, Curtis MA, Gibbons HM, Mee EW, Bergin PS, Teoh HH, et al. Doublecortin expression in the normal and epileptic adult human brain [Internet]. Eur J Neurosci 2008; 28: 2254-65.
  28. Liu RSN, Lemieux L, Bell GS, Hammers A, Sisodiya SM, Bartlett PA, et al. Progressive neocortical damage in epilepsy. Ann Neurol 2003; 53: 312-324.
  29. McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, et al. The spectrum of disease in chronic traumatic encephal- opathy [Internet]. Brain 2013; 136: 43-64.
  30. Oyegbile TO, Dow C, Jones J, Bell B, Rutecki P, Sheth R, et al. The nature and course of neuropsychological morbidity in chronic tem- poral lobe epilepsy [Internet]. Neurology 2004; 62: 1736-42.
  31. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease [Internet]. Neuron 2007; 55: 697-711.
  32. Pooler AM, Phillips EC, Lau DHW, Noble W, Hanger DP. Physiological release of endogenous tau is stimulated by neuronal ac- tivity [Internet]. EMBO Rep 2013; 14: 389-94.
  33. Sheng JG, Boop FA, Mrak RE, Griffin WST. Increased Neuronal b-Amyloid Precursor Protein Expression in Human Temporal Lobe Epilepsy: Association with Interleukin-1 Immunoreactivity. J Neurochem. 1994; 63: 1872-79.
  34. Spillantini MG, Goedert M. Tau pathology and neurodegeneration [Internet]. Lancet Neurol 2013; 12: 609-22.
  35. Springer JA, Binder JR, Hammeke TA, Swanson SJ, Frost JA, Bellgowan PS, et al. Language dominance in neurologically normal and epilepsy subjects: a functional MRI study [Internet]. Brain 1999; 122 (Pt 1): 2033-46.
  36. Srikandarajah N, Martinian L, Sisodiya SM, Squier W, Blumcke I, Aronica E, et al. Doublecortin expression in focal cortical dysplasia in epilepsy [Internet]. Epilepsia 2009; 50: 2619-28.
  37. Tellez-Zenteno JF, Matijevic S, Wiebe S. Somatic comorbidity of epi- lepsy in the general population in Canada [Internet]. Epilepsia 2005; 46: 1955-62.
  38. Thom M, Liu JYW, Thompson P, Phadke R, Narkiewicz M, Martinian L, et al. Neurofibrillary tangle pathology and Braak sta- ging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study [Internet]. Brain 2011; 134: 2969-81.
  39. Thom M. Review: hippocampal sclerosis in epilepsy: a neuropathology review [Internet]. Neuropathol Appl Neurobiol 2014; 40: 520-43.
  40. Thompson PJ, Baxendale SA, McEvoy AW, Duncan JS. Cognitive outcomes of temporal lobe epilepsy surgery in older patients [Internet]. Seizure 2015; 29: 41-5.
  41. Vuono R, Winder-Rhodes S, de Silva R, Cisbani G, Drouin-Ouellet J, Spillantini MG, et al. The role of tau in the pathological process and clinical expression of Huntington's disease [Internet]. Brain 2015; 138: 1907-18.
  42. Wolfe MS. The role of tau in neurodegenerative diseases and its po- tential as a therapeutic target [Internet]. Scientifica (Cairo) 2012; 2012: 796024.
  43. Xiong K, Luo D-W, Patrylo PR, Luo X-G, Struble RG, Clough RW, et al. Doublecortin-expressing cells are present in layer II across the adult guinea pig cerebral cortex: partial colocalization with mature interneuron markers [Internet]. Exp Neurol 2008; 211: 271-82.
  44. Zhang X-M, Cai Y, Chu Y, Chen E-Y, Feng J-C, Luo X-G, et al. Doublecortin-expressing cells persist in the associative cerebral cortex and amygdala in aged nonhuman primates [Internet]. Front Neuroanat 2009; 3: 17.

Cited by

Sorted by citations

Authors
Tai, X. Y., Koepp, M., Duncan, J. S., Fox, N., Thompson, P., Baxendale, S., Liu, J. Y. W., Reeves, C., Michalak, Z., & Thom, M.
Affiliations
  • National Hospital for Neurology and Neurosurgery (GB)
  • UCL Queen Square Institute of Neurology (GB)
Corresponding author
Thom, Maria
Venue
Brain
Published
2016-08-07
Volume
139
Issue
9
Pages
2441-2455
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2513581974
Cited by
291
References
4
Citations by year
2026: 25 · 2025: 35 · 2024: 40 · 2023: 31 · 2022: 29 · 2021: 35 · 2020: 30 · 2019: 32 · 2018: 21 · 2017: 9 · 2016: 4
FWCI
19.55
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • WestminsterResearch (University of Westminster) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institute for Health and Care Research (NF-SI-0513-10134, NF-SI-0509-10161, NF-SI-0508-10123, NF-SI-0515-10000)
  • European Commission (2007–2013, 602102)
  • University College London Hospitals NHS Foundation Trust
  • Epilepsy Society
  • Medical Research Council (MR/JO127OX/1, 602102, MR/J01270X/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
hyperphosphorylated tau, temporal lobe epilepsy, drug-resistant epilepsy, cognitive decline, temporal lobectomy, neuropil threads, neurofibrillary tangles, Braak staging, Alzheimer's disease, chronic traumatic encephalopathy, verbal learning, verbal memory, hippocampus, postoperative cognitive function, neurodegeneration
MeSH terms
Drug Resistant Epilepsy, Aged, Epilepsy, Temporal Lobe, Female, Humans, Male, Middle Aged, tau Proteins, Tauopathies, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review